This news is delayed by 15 minutes, sign up now to get live news & full features.
MLTX MOONLAKE IMMUNOTHERAPEUTICS
+ add to watchlist
$12.64
moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Mkt Cap: $807.14M
52 Week High: $62.75
P/E: 0.00
52 Week Low: $5.95
Dividend: $0.00
Shares Outstanding: 63.7M